Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer

Authors:

Abstract
Allostatic load (AL) is a cumulative measure of physiologic damage secondary to cognitive-emotional responses and perceptions to socioenvironmental stressors (ie, low socioeconomic status).1 McEwen and Stellar’s seminal article2 on AL defines it as the “cost of chronic exposure to fluctuating or heightened neural or neuroendocrine response resulting from repeated or chronic environmental challenge(s).” AL is measured by combining primary mediators (eg, cortisol) of the hypothalamic-pituitary-adrenal axis and the sympathetic adrenal medullary pathway, secondary outcomes of the hypothalamic-pituitary-adrenal axis and sympathetic adrenal medullary pathway (eg, c-reactive protein), and tertiary outcomes (eg, cancer) into a composite score.3-5 Although no reference standard of biomarkers are used to calculate AL, most studies use a combination of secondary and tertiary outcomes.6,7 Emerging literature suggests elevated AL (ie, an indicator of worsened physiologic dysregulation), is associated with exposure to adverse socioenvironmental stressors (eg, low socioeconomic status, membership in marginalized and minoritized groups),8 an increased risk of developing chronic diseases such as cancer,9 and worse all-cause mortality.10

This publication has 33 references indexed in Scilit: